Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid. (Q36415031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

K Bukhave

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J Elmgreen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

I Ahnfelt-Rønne

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 June 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

577-582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01296156

6 October 2019

exact match

0 references

cites work

Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis

1 reference

12 December 2020

Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development

1 reference

12 December 2020

Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway

1 reference

12 December 2020

Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

1 reference

12 December 2020

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils

1 reference

12 December 2020

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis

1 reference

12 December 2020

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

12 December 2020

Inhibition of phospholipase

1 reference

12 December 2020

The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger

1 reference

12 December 2020

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment

1 reference

12 December 2020

Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease

1 reference

12 December 2020

Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease

1 reference

12 December 2020

Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine

1 reference

12 December 2020

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

12 December 2020

Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls

1 reference

12 December 2020

Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis

1 reference

12 December 2020

Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine

1 reference

12 December 2020

National Cooperative Crohn's Disease Study: results of drug treatment

1 reference

12 December 2020

Studies of prostaglandins and sulphasalazine in ulcerative colitis

1 reference

12 December 2020

Is N-acetylation of 5-aminosalicylic acid reversible in man?

1 reference

12 December 2020

Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent

1 reference

12 December 2020

Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats

1 reference

12 December 2020

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

1 reference

12 December 2020

Inhibition of leucocyte motility by drugs used in ulcerative colitis

1 reference

12 December 2020

A simple method for the isolation and purification of total lipides from animal tissues

1 reference

12 December 2020

Sulfasalazine. Adverse effects and desensitization

1 reference

12 December 2020

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

1 reference

12 December 2020

Clinical Pharmacokinetics of Sulphasalazine

1 reference

12 December 2020

Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis

1 reference

12 December 2020

Arachidonic acid metabolism in human neutrophils: lack of effect of cyclosporine A.

1 reference

12 December 2020

Analgesic ingestion and other factors preceding relapse in ulcerative colitis

1 reference

12 December 2020

Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa

1 reference

12 December 2020

Benoxaprofen in the treatment of active ulcerative colitis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01296156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882965%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference